ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30918-5mg |
|
443103-97-7 |
A2A receptor antagonist 1
|
0 | C16H12FN5O | |
GC30918-1mg |
|
443103-97-7 |
A2A receptor antagonist 1
|
0 | C16H12FN5O | |
GC30918-10mM(1mLinDMSO) |
|
443103-97-7 |
A2A receptor antagonist 1
|
0 | C16H12FN5O | |
GC30917-100mg |
|
1443373-17-8 |
AM-2099
|
0 | C19H13F3N4O3S2 | |
GC30917-50mg |
|
1443373-17-8 |
AM-2099
|
0 | C19H13F3N4O3S2 | |
GC30917-25mg |
|
1443373-17-8 |
AM-2099
|
0 | C19H13F3N4O3S2 | |
GC30917-10mg |
|
1443373-17-8 |
AM-2099
|
0 | C19H13F3N4O3S2 | |
GC30917-5mg |
|
1443373-17-8 |
AM-2099
|
0 | C19H13F3N4O3S2 | |
GC30917-2mg |
|
1443373-17-8 |
AM-2099
|
0 | C19H13F3N4O3S2 | |
GC30917-10mM(1mLinDMSO) |
|
1443373-17-8 |
AM-2099
|
0 | C19H13F3N4O3S2 | |
GC30916-100mg |
|
96392-15-3 |
PD 117519 (CI947)
|
0 | C19H21N5O4 | |
GC30916-50mg |
|
96392-15-3 |
PD 117519 (CI947)
|
0 | C19H21N5O4 | |
GC30916-10mg |
|
96392-15-3 |
PD 117519 (CI947)
|
0 | C19H21N5O4 | |
GC30916-5mg |
|
96392-15-3 |
PD 117519 (CI947)
|
0 | C19H21N5O4 | |
GC30916-10mM(1mLinDMSO) |
|
96392-15-3 |
PD 117519 (CI947)
|
0 | C19H21N5O4 | |
GC30915-100mg |
|
794568-90-4 |
BAY 73-6691 racemate
|
0 | C15H12ClF3N4O | |
GC30915-50mg |
|
794568-90-4 |
BAY 73-6691 racemate
|
0 | C15H12ClF3N4O | |
GC30915-25mg |
|
794568-90-4 |
BAY 73-6691 racemate
|
0 | C15H12ClF3N4O | |
GC30915-10mg |
|
794568-90-4 |
BAY 73-6691 racemate
|
0 | C15H12ClF3N4O | |
GC30915-5mg |
|
794568-90-4 |
BAY 73-6691 racemate
|
0 | C15H12ClF3N4O | |